Search Contract Opportunities

TOBACCO ANALYSIS AND ENGINEERING LABORATORY SERVICES

ID: FDA-20-1236379 • Type: Solicitation • Match:  90%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

Questions Due at 10AM EST on 10/27/2021

Proposal Due at 10AM EST on 11/15/2021

When submitting questions and proposals, please include in the subject FDA-RFP-20-1236379

Overview

Response Deadline
Nov. 15, 2021, 10:00 a.m. EST Past Due
Posted
Oct. 21, 2021, 5:01 p.m. EDT
Set Aside
None
Place of Performance
Not Provided
Source

Current SBA Size Standard
$28 Million
Est. Level of Competition
Average
On 10/21/21 Center for Tobacco Products issued Solicitation FDA-20-1236379 for TOBACCO ANALYSIS AND ENGINEERING LABORATORY SERVICES due 11/15/21. The opportunity was issued full & open with NAICS 541720 and PSC B537.
Primary Contact
Name
Telisha Wilson   Profile
Phone
None

Documents

Posted documents for Solicitation FDA-20-1236379

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

IDV Awards

Indefinite delivery vehicles awarded through Solicitation FDA-20-1236379

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation FDA-20-1236379

Similar Active Opportunities

Open contract opportunities similar to Solicitation FDA-20-1236379

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > FOOD AND DRUG ADMINISTRATION > FDA CENTER FOR TOBACCO PRODUCTS
FPDS Organization Code
7524-75DKKI
Source Organization Code
500024275
Last Updated
Oct. 21, 2021
Last Updated By
telisha.venable@fda.hhs.gov
Archive Date
Nov. 30, 2021